REGISTERED NUMBER: 03481415 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025

FOR

CHALICE PHARMACIES LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

M S Mann

SECRETARY:

Mrs B K Mann

REGISTERED OFFICE:

1110 Elliott Court

Coventry Business Park

Herald Avenue

Coventry

West Midlands

CV5 6UB

REGISTERED NUMBER:

03481415 (England and Wales)

ACCOUNTANTS:

LDP Luckmans

1110 Elliott Court

Coventry Business Park

Herald Avenue

Coventry

West Midlands

CV5 6UB

FIXED ASSETS

Intangible assets

4

1,101,941

1,251,349

Tangible assets

5

233,411

277,679

1,335,352

1,529,028

CURRENT ASSETS

Stocks

205,025

202,433

Debtors

6

1,109,792

1,101,039

Cash at bank and in hand

440,648

504,940

1,755,465

1,808,412

CREDITORS

Amounts falling due within one year

7

1,394,460

1,299,888

NET CURRENT ASSETS

361,005

508,524

TOTAL ASSETS LESS CURRENT LIABILITIES

1,696,357

2,037,552

CREDITORS

Amounts falling due after more than one year

8

(1,576,555

)

(1,717,832

)

PROVISIONS FOR LIABILITIES

(48,974

)

(59,753

)

NET ASSETS

70,828

259,967

CAPITAL AND RESERVES

Called up share capital

240

240

Retained earnings

9

70,588

259,727

SHAREHOLDERS' FUNDS

70,828

259,967

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 13 October 2025 and were signed by:

M S Mann - Director

1.	STATUTORY INFORMATION

Chalice Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 1997, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Long leasehold

-

2% on cost

Fixtures and fittings

-

15% on reducing balance

Motor vehicles

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 53 (2024 - 51 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 February 2024

and 31 January 2025

3,051,160

AMORTISATION

At 1 February 2024

1,799,811

Amortisation for year

149,408

At 31 January 2025

1,949,219

NET BOOK VALUE

At 31 January 2025

1,101,941

At 31 January 2024

1,251,349

5.	TANGIBLE FIXED ASSETS

Fixtures

Long

and

Motor

leasehold

fittings

vehicles

Totals

£

£

£

£

COST

At 1 February 2024

and 31 January 2025

57,679

619,114

100,145

776,938

DEPRECIATION

At 1 February 2024

19,010

452,742

27,507

499,259

Charge for year

1,154

24,955

18,159

44,268

At 31 January 2025

20,164

477,697

45,666

543,527

NET BOOK VALUE

At 31 January 2025

37,515

141,417

54,479

233,411

At 31 January 2024

38,669

166,372

72,638

277,679

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

612,405

633,927

Other debtors

98,569

94,835

Sundry debtors

243,433

223,339

Directors' current accounts

135,000

130,000

Prepayments

20,385

18,938

1,109,792

1,101,039

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

113,448

92,443

Hire purchase contracts

11,225

12,370

Trade creditors

1,043,277

1,092,608

Tax

85,096

75,596

Social security and other taxes

13,600

8,193

Other creditors

3,508

2,454

Sundry Creditors

69,125

-

Accrued expenses

55,181

16,224

1,394,460

1,299,888

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank Loans - More than 1yr

1,548,049

1,678,101

Hire purchase contracts

28,506

39,731

1,576,555

1,717,832

9.

RESERVES

Retained

earnings

£

At 1 February 2024

259,727

Profit for the year

73,861

Dividends

(263,000

)

At 31 January 2025

70,588

10.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2025 and 31 January 2024:

2025

2024

£

£

M S Mann

Balance outstanding at start of year

97,500

69,000

Amounts advanced

139,000

28,500

Amounts repaid

(101,500

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

135,000

97,500

B S Atwal

Balance outstanding at start of year

32,500

23,000

Amounts advanced

-

9,500

Amounts repaid

(32,500

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

32,500